ArticleAbdominal radiology (New York)2026
Peritumoral ultrasound-driven multimodal AI model for predicting lymphovascular space invasion and prognosis in cervical cancer.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeAccurate preoperative assessment of lymphovascular space invasion (LVSI) in cervical cancer (CC) remains challenging despite its importance for treatment planning and risk stratification. This study aimed to develop and evaluate a hybrid model integrating peritumoral ultrasound radiomics features, deep learning features, and clinical data for preoperative prediction of LVSI in CC. Additionally, we assessed the model's prognostic value for disease-free survival (DFS) and explored LVSI-associated molecular pathways using data from The Cancer Genome Atlas (TCGA).
methodsIn a retrospective cohort (n = 241) and a prospective cohort (n = 51), radiomics features were extracted from tumor and peritumoral regions of interest on ultrasound images. Least absolute shrinkage and selection operator regression and machine learning classifiers generated a radiomics score (Rad-score). Simultaneously, transfer learning with pre-trained convolutional neural networks constructed a deep learning score (DL-score). A hybrid model integrating clinical factors, Rad-score, and DL-score was developed. Model performance was evaluated using the area under the curve (AUC). Furthermore, prognostic value (Kaplan-Meier analysis), model interpretability using Shapley Additive Explanations (SHAP), and biological pathways were assessed.
resultsOverall, 292 women were included: 188 in the training set, 53 in the internal validation set, and 51 in the prospective testing set. The hybrid model achieved the highest performance (AUC: 0.79, 95%CI: 0.66-0.92; sensitivity: 0.85, 95%CI: 0.71-0.98) in the prospective testing set, outperforming the single-modality models. Exploratory survival analysis showed shorter DFS in the high-risk group (P < 0.05). SHAP analysis identified the DL-score as the primary predictor. Biologically, the Wnt/β-catenin pathway was significantly enriched in LVSI-positive patients.
conclusionsThe hybrid model, evaluated in a prospective cohort, showed potential for preoperative LVSI prediction and DFS risk stratification in CC. TCGA analysis showed Wnt/β-catenin enrichment in LVSI-positive tumors, providing complementary biological context. Further validation in larger independent multicenter cohorts is needed before clinical application.
Indexed as
Identifiers
42848195What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.